Collaborative research on influenza and other respiratory pathogens in South Africa
Closed Posted
- Opportunity number
- RFA-IP-24-017
- Agency
-
Centers for Disease Control and Prevention
Department of Health and Human Services
- Applications due
- Award size
- $1,000,000 to $2,500,000
Opportunity facts
- Assistance listings
- Funding instrument
- Cooperative Agreement
- Category
-
- Health
- Eligible applicants
-
- Other
Opportunity details come from Grants.gov. Updated .
About this opportunity
The Centers for Disease Control and Prevention's National Center for Immunization and Respiratory Diseases seeks to initiate a cooperative agreement with the National Institute for Communicable Diseases in South Africa to conduct research on influenza and other respiratory pathogens through March 7, 2024. Research must focus on surveillance, preventive tools and strategies, and interventions in high-risk populations. The National Institute for Communicable Diseases in South Africa must apply, with evaluation based on significance, investigators, innovation, approach, and environment. Up to one award of $15 million total over five years will be granted, with an estimated $2.5 million for the first year of work conducted in South Africa in collaboration with regional and provincial health organizations.
This cooperative agreement will provide up to $15 million in total funding over five years from September 1, 2024 through August 31, 2029. The primary place of performance for research on influenza and other respiratory diseases will be South Africa, in collaboration with regional and sub-regional health authorities.
Synopsis
The purpose of this notice of funding opportunity is to conduct research studies on influenza and other respiratory pathogens of public health import in South Africa. The National Center for Immunization and Respiratory Diseases (NCIRD) in CDC is seeking to initiate a cooperative agreement with the National Institute for Communicable Diseases (NICD), Republic of South Africa, to conduct research on surveillance (inclusive of the epidemiology, disease burden, transmission, and laboratory methods), preventive tools and strategies (e.g., vaccines, antivirals), and strategies for increasing coverage of morbidity and mortality mitigating interventions. Data will be used to inform prioritization of public health interventions in high-risk populations in South Africa, the region, and globally.
Files
| File | Type | Posted |
|---|---|---|
| Foa_Content_of_RFA-IP-24-017 final.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity